Please login to the form below

Not currently logged in
Email:
Password:

GE’s Fraser Black joins BioCity Scotland as MD

Replaces Ian Webster at Scottish life sciences hub

Fraser Black has been appointed as managing director at BioCity Scotland – a life sciences hub based at an old MSD facility in central Scotland.

He joins from GE Life Sciences where he was global services solutions director, and takes over from Ian Webster who had been managing director at BioCity Scotland since its launch in January, 2012.

In his new role, Black will oversee the collection of new bioscience and life sciences companies, including relationship-building with both corporate partners and the local community.

“In Newhouse, we have the resources and exceptional facilities to build a world class hub of successful life science businesses in the central belt of Scotland, and I believe the potential to add real value to the economy is enormous,” said Black. “This is the goal I will work towards as we collectively build the BioCity community here.”

Black had been at GE Life Sciences 2005 having previously held VP positions with Amersham Bioscience in both bioscience services and sales and marketing. He was also president of Hoefer Pharmacia Biotech.

“He brings business development experience honed in the international life sciences arena, as well as world-class team-building skills so we are in very good hands,” said Dr Louis Nisbet, BioCity Scotland chair.

9th July 2012

Share



Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Door Communications

Red Door Communications (RDC) is the health and wellbeing communications consultancy that lives and breathes originality and is built on...

Latest intelligence

Online Physician Communities
Study highlights value of internet for doctors in Eastern Europe
Electronic direct mail is proving popular as online access increases...
England’s clinical commissioning landscape
Who are the real masters in the new NHS?...
How will the new landscape of Hep C treatments affect patients?
The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....